FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine, namely to oncology, and can be applied for application of sodium metaarsenite for production of therapeutic agent for treatment of taxane- and cisplatin-resistant forms of cancer. For this purpose composition, which contains sodium metaarsenite and composition, which contains paclitaxel, decetaxel or cisplatin, is included into therapeutic agent. Anti-tumour agents for treatment of taxane- and cisplatin-resistant forms of cancer are also claimed.
EFFECT: group of inventions makes it possible to reduce quantity of stem cells and mature cancer cells, resistant to action of medications, in patients.
10 cl, 2 tbl, 14 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS FOR TREATING CANCER | 2009 |
|
RU2508116C2 |
| PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING CANCER AND ITS METASTASES | 2006 |
|
RU2401662C2 |
| METHOD OF TREATING CANCER (VERSIONS) | 2006 |
|
RU2447889C2 |
| NANOPARTICLE, CONTAINING RAPAMYCIN AND ALBUMIN AS ANTI-CANCER AGENT | 2008 |
|
RU2483714C2 |
| USE OF ARSENIC COMPOUNDS FOR PAIN MANAGEMENT AND INFLAMMATION TREATMENT | 2008 |
|
RU2630574C2 |
| USE OF ARSENIC COMPOUNDS TO TREAT TISSUE OR ORGAN REJECTION | 2013 |
|
RU2665362C2 |
| COMBINATION OF SIROSINGOPIN AND MITOCHONDRIAL INHIBITORS FOR TREATMENT OF CANCER AND FOR IMMUNOSUPPRESSION | 2012 |
|
RU2602937C2 |
| IMMUNE-MODIFYING PARTICLES FOR CANCER TREATMENT | 2019 |
|
RU2794261C2 |
| METHODS OF TREATING CANCER | 2013 |
|
RU2657749C2 |
| SUPPRESSION OF CANCER METASTASES | 2010 |
|
RU2571502C2 |
